Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A survey on infection control in emergency departments in Japan.
Kudo D, Sasaki J, Ikeda H, Shiino Y, Shime N, Mochizuki T, Morita M, Soeda H, Ohge H, Lee JJ, Fujita M, Miyairi I, Kato Y, Watanabe M, Yokota H; Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group. Kudo D, et al. Among authors: soeda h. Acute Med Surg. 2018 Jul 30;5(4):374-379. doi: 10.1002/ams2.360. eCollection 2018 Oct. Acute Med Surg. 2018. PMID: 30338085 Free PMC article.
Determinants of clinic doctors' attitudes concerning antimicrobial prescription for patients with common colds or bronchitis: Additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases.
Morioka S, Gu Y, Tsuzuki S, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N. Morioka S, et al. Among authors: soeda h. J Infect Chemother. 2021 Feb;27(2):131-138. doi: 10.1016/j.jiac.2020.11.017. Epub 2021 Jan 2. J Infect Chemother. 2021. PMID: 33397586
Phase II trial of cetuximab plus irinotecan for oxaliplatin- and irinotecan-based chemotherapy-refractory patients with advanced and/or metastatic colorectal cancer: evaluation of efficacy and safety based on KRAS mutation status (T-CORE0801).
Soeda H, Shimodaira H, Gamoh M, Ando H, Isobe H, Suto T, Takahashi S, Kakudo Y, Amagai K, Mori T, Watanabe M, Yamaguchi T, Kato S, Ishioka C. Soeda H, et al. Oncology. 2014;87(1):7-20. doi: 10.1159/000360989. Epub 2014 Jun 24. Oncology. 2014. PMID: 24968756 Clinical Trial.
123 results